Weiss Cary N, Ito Keisuke
Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein Cancer Center and Einstein Diabetes Research Center, Albert Einstein College of Medicine, Bronx, NY, United States.
Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein Cancer Center and Einstein Diabetes Research Center, Albert Einstein College of Medicine, Bronx, NY, United States.
Int Rev Cell Mol Biol. 2017;334:99-175. doi: 10.1016/bs.ircmb.2017.03.007. Epub 2017 Apr 21.
MicroRNAs (MiRNAs) are a class of endogenously encoded ~22 nucleotide, noncoding, single-stranded RNAs that contribute to development, body planning, stem cell differentiation, and tissue identity through posttranscriptional regulation and degradation of transcripts. Given their importance, it is predictable that dysregulation of MiRNAs, which target a wide variety of transcripts, can result in malignant transformation. In this review, we explore the discovery of MiRNAs, their mechanism of action, and the tools that aid in their discovery and study. Strikingly, many of the studies that have expanded our understanding of the contributions of MiRNAs to normal physiology and in the development of diseases have come from studies in the hematopoietic system and hematologic malignancies, with some of the earliest identified functions for mammalian MiRNAs coming from observations made in leukemias. So, with a special focus on the hematologic system, we will discuss how MiRNAs contribute to differentiation of stem cells and how dysregulation of MiRNAs contributes to the development of malignancy, by providing examples of specific MiRNAs that function as oncogenes or tumor suppressors, as well as of defects in MiRNA processing. Finally, we will discuss the promise of MiRNA-based therapeutics and challenges for the future study of disease-causing MiRNAs.
微小RNA(miRNA)是一类内源性编码的约22个核苷酸的非编码单链RNA,通过转录后调控和转录本降解,参与发育、身体规划、干细胞分化和组织特性的维持。鉴于其重要性,可以预测,靶向多种转录本的miRNA失调会导致恶性转化。在本综述中,我们探讨了miRNA的发现、其作用机制以及有助于其发现和研究的工具。引人注目的是,许多扩展我们对miRNA在正常生理学和疾病发展中作用理解的研究都来自造血系统和血液系统恶性肿瘤的研究,哺乳动物miRNA最早确定的一些功能来自白血病中的观察结果。因此,特别关注血液系统,我们将通过提供作为癌基因或肿瘤抑制因子发挥作用的特定miRNA的例子以及miRNA加工缺陷的例子,讨论miRNA如何促进干细胞分化以及miRNA失调如何促进恶性肿瘤的发展。最后,我们将讨论基于miRNA的治疗方法的前景以及未来研究致病miRNA所面临的挑战。